Published in J Pharm Biomed Anal on June 29, 2004
Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. Br J Clin Pharmacol (2006) 1.03
Quantification of the transporter substrate fexofenadine in cell lysates by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom (2011) 0.85
Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. Br J Clin Pharmacol (2006) 0.85
Validation and application of a liquid chromatography-tandem mass spectrometric method for quantification of the drug transport probe fexofenadine in human plasma using 96-well filter plates. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.79
Does Ethnic Variability Exist in the Systemic Exposures of OATP1A2 Substrates-Fexofenadine in Taiwanese? Indian J Pharm Sci (2016) 0.75
Stability-indicating HPLC Method for Simultaneous Determination of Montelukast and Fexofenadine Hydrochloride. Indian J Pharm Sci (2013) 0.75
Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer (2012) 2.01
Effect of dose timing in relation to food intake on systemic exposure to blonanserin. Eur J Clin Pharmacol (2010) 1.47
Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. J Gastroenterol Hepatol (2008) 1.45
Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry (2002) 1.36
Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med (2011) 1.31
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes. Br J Clin Pharmacol (2005) 1.21
Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. Clin Pharmacol Ther (2005) 1.17
Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet (2005) 1.11
Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population. Br J Clin Pharmacol (2008) 1.08
Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes. Br J Clin Pharmacol (2003) 1.08
Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes. Br J Clin Pharmacol (2006) 1.06
Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography. J Pharm Biomed Anal (2006) 1.06
Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief #962. Online. Hum Mutat (2007) 1.03
Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. Br J Clin Pharmacol (2006) 1.03
Prevalence of metabolic syndrome among patients with schizophrenia in Japan. Schizophr Res (2010) 1.02
Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes. Br J Clin Pharmacol (2004) 1.01
The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics. Clin Pharmacokinet (2005) 0.97
Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. Clin Cancer Res (2011) 0.95
Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. J Gastroenterol Hepatol (2006) 0.95
The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. Pharmacogenet Genomics (2011) 0.95
Gender differences in factors associated with suicidal ideation and depressive symptoms among middle-aged workers in Japan. Ind Health (2012) 0.94
Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects. Life Sci (2003) 0.94
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations. Eur J Clin Pharmacol (2007) 0.93
Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.93
Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci (2007) 0.90
Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation. Epilepsy Res (2007) 0.90
Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.88
Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker. Drugs R D (2005) 0.87
Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration. Eur J Clin Pharmacol (2007) 0.87
Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome. Am J Med Genet B Neuropsychiatr Genet (2003) 0.87
Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.87
Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers. Xenobiotica (2010) 0.87
Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes. J Clin Pharmacol (2004) 0.87
No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan. Ann Gen Psychiatry (2012) 0.86
[A case of unresectable advanced gastric cancer with Trousseau syndrome]. Gan To Kagaku Ryoho (2009) 0.86
No association between bone mass and prolactin levels among patients with schizophrenia. Hum Psychopharmacol (2011) 0.86
Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population. BMC Psychiatry (2010) 0.85
Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia. J Clin Pharmacol (2003) 0.85
Effect of grapefruit juice in relation to human pharmacokinetic study. Curr Clin Pharmacol (2006) 0.85
Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. Br J Clin Pharmacol (2006) 0.85
Effect of age and disease on bone mass in Japanese patients with schizophrenia. Ann Gen Psychiatry (2012) 0.85
Sensitive determination of itraconazole and its active metabolite in human plasma by column-switching high-performance liquid chromatography with ultraviolet detection. Ther Drug Monit (2006) 0.85
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition. Clin Pharmacol Ther (2005) 0.85
Intratracheal delivery of CX3CL1-expressing mesenchymal stem cells to multiple lung tumors. Mol Med (2009) 0.85
Sex-specific effects of subjective memory complaints with respect to cognitive impairment or depressive symptoms. Psychiatry Clin Neurosci (2014) 0.84
Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine. Br J Clin Pharmacol (2005) 0.84
Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia. Ann Gen Psychiatry (2011) 0.84
Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia. Neuropsychiatr Dis Treat (2013) 0.84
Neuroleptic malignant syndrome induced by lamotrigine. Clin Neuropharmacol (2013) 0.84
Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients. Ther Drug Monit (2002) 0.84
Dietary patterns are associated with obesity in Japanese patients with schizophrenia. BMC Psychiatry (2014) 0.83
Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil. Br J Clin Pharmacol (2009) 0.83
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve. Eur J Clin Pharmacol (2006) 0.82
Cytochrome P450 2C19 genetic polymorphisms in Ugandans. Eur J Clin Pharmacol (2008) 0.82
A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies. J Sep Sci (2010) 0.82
Ankle brachial pressure index as a marker of apathy in a community-dwelling population. Int J Geriatr Psychiatry (2011) 0.82
Characteristics of the tree-drawing test in chronic schizophrenia. Psychiatry Clin Neurosci (2010) 0.82
Hearing impairment and cognitive function among a community-dwelling population in Japan. Ann Gen Psychiatry (2011) 0.82
Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status. Br J Clin Pharmacol (2006) 0.82
[Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia]. Nihon Shinkei Seishin Yakurigaku Zasshi (2011) 0.82
Pharmacokinetics of fexofenadine enantiomers in healthy subjects. Chirality (2007) 0.82
Depression increases the length of hospitalization for patients undergoing thoracic surgery: a preliminary study. Psychosomatics (2011) 0.82
Body mass index and quality of life among outpatients with schizophrenia in Japan. BMC Psychiatry (2013) 0.82
[A case of gastric adenosquamous carcinoma successfully treated with second-line chemotherapy (CPT-11 and CDDP)]. Gan To Kagaku Ryoho (2010) 0.81
A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: application of human pharmacokinetic study for measurement of CYP3A activity. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.81
Minor genetic variants of the dopamine D4 receptor (DRD4) polymorphism are associated with novelty seeking in healthy Japanese subjects. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.81
Body composition in patients with schizophrenia: Comparison with healthy controls. Ann Gen Psychiatry (2012) 0.81